Prospective Ascertainment for Late Effects Among Survivors of Cancer, Tumor, or a Related Illness
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,068
- 试验地点
- 1
- 主要终点
- establish a registry of DNA
研究概览
简要总结
The purpose of this study is to establish a registry of survivors of cancer, tumor, or a related illness.
研究设计
- 研究类型
- Observational
- 观察模型
- Family Based
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •English speaking
- •A personal history of cancer tumor, or a related illness
- •Followed in the the Adult Long Term Follow Up Program, Pediatric Long Term Follow Up Program, or Lymphoma Service at MSKCC
排除标准
- •Evidence of active progression of disease or recurrence
- •Neurocognitive deficits that impair ability to give informed consent.
结局指标
主要结局
establish a registry of DNA
时间窗: 4 years
For the purpose of facilitating future genetic laboratory investigations of late effects among of survivors of cancer, tumors, or a related illness. Patients in the ALTFU Program are followed for secondary malignant neoplasms and other adverse outcomes (so-called "late effects") including cardiomyopathy, pulmonary fibrosis, cardiac valvular pathology, osteoporosis, and others. The following data will be ascertained from each study participant: (1) family history information will be ascertained using the Family History Questionnaire (Appendix A); and (2) saliva or blood samples for genetic analysis.
次要结局
未报告次要终点